Literature DB >> 5925027

Sodium sulfate treatment of hypercalcemia.

Z H Chakmakjian, J E Bethune.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5925027     DOI： 10.1056/NEJM196610202751602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

Review 2.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

Review 3.  Recent progress in calcium metabolism: clinical application.

Authors:  G S Gordan
Journal:  Calif Med       Date:  1971-05

4.  [Phosphate treatment in hypercalcemia].

Authors:  H J Kistler; W Neubauer
Journal:  Klin Wochenschr       Date:  1970-06-15

5.  Hypercalciuria in sarcoidosis treated with inorganic phosphates.

Authors:  G O Thomas
Journal:  Br Med J       Date:  1969-04-12

6.  Nutritional rickets in 2 very low birthweight infants with chronic lung disease.

Authors:  A E Chudley; D R Brown; I R Holzman; K S Oh
Journal:  Arch Dis Child       Date:  1980-09       Impact factor: 3.791

7.  Immobilization hypercalcaemia due to low bone formation and responding to intravenous sodium sulphate.

Authors:  R A Evans; P J Lawrence; G Thanakrishnan; E Hills; S Y Wong; C R Dunstan
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

Review 8.  Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

Authors:  V Schulz
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

9.  Ionic interaction with bone mineral. V. Effect of Mg2+, Citrate3-, F- and SO4 negative 2 ion on the solubility, dissolution and growth of bone mineral.

Authors:  C Y Pak; E C Diller
Journal:  Calcif Tissue Res       Date:  1969-08-11

10.  Urinary crystalloid excretion in patients with inflammatory bowel disease.

Authors:  R I Breuer; E A Gelzayd; J K Kirsner
Journal:  Gut       Date:  1970-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.